Internal Medicine, Medical Oncology · Delray Beach, FL
NPI
1104874916
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
6282 Linton Blvd
Delray Beach, FL, 33484
Phone (561) 495-8307
Groups this clinician bills Medicare through
Medicare paid, 2024
$184K
3,628 services
Medicare patients, 2024
804
Average age 80
Drug cost, 2024
$7.2M
1,044 prescriptions
Company payments, 2025
$919
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hilary Gomolin was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 778 times for 359 patients. In total Hilary Gomolin billed 3,628 services in 13 codes, and Medicare paid $184K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 778 | 359 | $13.14 | $10K |
| 99214 Office E&M - Established | Office | 760 | 326 | $74.36 | $57K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 720 | 327 | $13.07 | $9,412 |
| 99214 Office E&M - Established | Facility | 714 | 313 | $74.61 | $53K |
| 99232 Hospital E&M - Subsequent | Facility | 218 | 91 | $63.32 | $14K |
| 99213 Office E&M - Established | Office | 79 | 68 | $49.48 | $3,909 |
| 99204 Office E&M - New | Office | 66 | 66 | $106.79 | $7,048 |
| 99213 Office E&M - Established | Facility | 52 | 48 | $47.99 | $2,496 |
| 99215 Office E&M - Established | Facility | 50 | 39 | $112.61 | $5,630 |
| 99215 Office E&M - Established | Office | 47 | 37 | $109.61 | $5,152 |
| 99204 Office E&M - New | Facility | 45 | 45 | $104.05 | $4,682 |
| 99222 Hospital E&M - Initial | Facility | 37 | 36 | $99.10 | $3,667 |
| 99223 Hospital E&M - Initial | Facility | 32 | 32 | $139.44 | $4,462 |
| 99205 Office E&M - New | Office | 12 | 12 | $147.54 | $1,770 |
| 99205 Office E&M - New | Facility | 11 | 11 | $146.20 | $1,608 |
By year: 2022 $161K for 2,080 services; 2023 $164K for 2,039 services; 2024 $184K for 3,628 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hilary Gomolin prescribed most often to Medicare patients was Hydroxyurea, with 86 prescriptions and refills. In total Hilary Gomolin wrote 1,044 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 86 | 238 | 29 | $2,771 |
| Eliquis Apixaban | 70 | 106 | 17 | $60K |
| Revlimid Lenalidomide | 65 | 65 | 19 | $1.2M |
| Lenalidomide Generic | 64 | 64 | 17 | $931K |
| Calquence Acalabrutinib Maleate | 58 | 58 | Under 11 | $878K |
| Levothyroxine Sodium Generic | 46 | 132 | 18 | $790 |
| Acyclovir Generic | 40 | 78 | 12 | $631 |
| Xarelto Rivaroxaban | 37 | 74 | 11 | $40K |
| Prednisone Generic | 29 | 50 | Under 11 | $230 |
| Warfarin Sodium Generic | 27 | 57 | Under 11 | $241 |
| Alprazolam Generic | 23 | 23 | 11 | $153 |
| Brukinsa Zanubrutinib | 23 | 23 | Under 11 | $347K |
| Venclexta Venetoclax | 22 | 22 | Under 11 | $303K |
| Jaypirca Pirtobrutinib | 21 | 21 | Under 11 | $405K |
| Empaveli Pegcetacoplan | 21 | 21 | Under 11 | $946K |
Brand drugs: - claims; generic drugs: 584 claims; opioid claims: 60.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hilary Gomolin $919 ($919 in general payments such as food, travel and fees) from 19 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $173.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $173 |
| Pfizer Inc. PFE | 5 | $122 |
| Daiichi Sankyo Inc. 4568.T | 3 | $82.34 |
| Janssen Biotech, Inc. JNJ | 3 | $69.64 |
| Caris MPI, Inc. | 2 | $55.34 |
| Lilly USA, LLC LLY | 2 | $51.37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49.31 |
| Array Biopharma Inc PFE | 2 | $48.99 |
| Genentech USA, Inc. ROG.SW | 1 | $34.49 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $31.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.